Position in GILD
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$575,478
+$50,054 QoQ
Shares Held
4,555
+20.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#1,317
of 2,266 holders
Holding Since
Dec 2022
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Astoria Portfolio Advisors LLC. holds $9,341,449 across 9 Drug Manufacturers - General names. GILD ranks #5 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
10,976 | $2,762,000 | |
| 2 | LLY |
ELI LILLY & Co
|
2,257 | $2,707,113 | |
| 3 | JNJ |
Johnson & Johnson
|
5,374 | $1,364,834 | |
| 4 | AMGN |
Amgen Inc
|
2,028 | $734,379 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
4,555 | $575,478 | |
| 6 | AZN |
Astrazeneca PLC
|
2,426 | $460,018 | |
| 7 | NVS |
Novartis AG
|
1,831 | $286,954 | |
| 8 | MRK |
Merck & Co., Inc.
|
1,888 | $242,608 |
All Filings in GILD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $575,478 | 4,555 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $525,424 | 3,770 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $457,083 | 3,724 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $435,120 | 3,920 | Shares | Sole | 2025-10-09 | |
| 2023-06-30 | $238,223 | 3,091 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $253,224 | 3,052 | Shares | Sole | 2023-04-05 | |
| 2022-12-31 | $334,729 | 3,899 | Shares | Sole | 2023-01-23 | |
| No filing history on record for this holder in this stock. | ||||||